Opinion: Who should get to see the neurologist first: the sick or the at-risk?
Once a year, Jessi Keavney goes to see her neurologist. During the visit, the doctor asks if…
Category: neurology
Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome
A year ago, after much fanfare and controversy, the Food and Drug Administration approved Eisai…
Opinion: What’s going on in Joe Biden’s brain?
At the Democratic National Convention in Chicago on Monday night, President Biden took the stage…
ALS patient lived with a brain-computer interface for 7 years. Here’s what researchers learned
Brain-computer interfaces are still years, and several FDA approvals, away from being available on the…
Listen: The long journey to make malaria vaccines, and Sarepta’s ties with patient advocates
Why has it taken so long for the world to get malaria vaccines? What relationship…
STAT+: Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes…
Opinion: Survey: Neurologists split on prescribing new Alzheimer’s treatments
As more than 7,500 clinicians and researchers converge in Philadelphia for the Alzheimer’s Association International…
A neurological disorder stole her voice. Jennifer Wexton takes it back on the House floor
When Jennifer Wexton rises Thursday to speak on the House floor, something she has done…
Robotic aid helped improve balance, gait in children with cerebral palsy
For many kids with cerebral palsy, walking is taxing. They might spend thousands of hours…
After Biden debate performance, experts reflect on difference between ‘normal aging’ and something more
In the days after Thursday’s presidential debate, one of the questions that was asked on…
STAT+: Biogen, Ionis drop ALS treatment after study failure
A plan to use new genetic techniques to treat non-genetic forms of ALS failed in…
To detect risk of stroke, tiny probe acts ‘like a microscope’ inside brain’s blood vessels
To better understand problems in the brain’s blood vessels that may lead to stroke, we…
Opinion: Health care needs a new profession: neuroimaging counseling
Until recently, getting an MRI meant traveling to the hospital. But a new generation of…
STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show
NEW YORK — By the time Peter Bauman considered deep brain stimulation, he was desperate….
STAT+: Big biotech names roll out Seaport Therapeutics, as interest in neuropsychiatric drugs swells
The team behind Karuna Therapeutics, which was recently snapped up in a multibillion-dollar deal, on…
Parkinson’s disease may be helped by GLP-1 drug, new study finds
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective…
STAT+: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines
One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry. It was…
STAT+: Annovis Bio delivers candor on its Parkinson’s study, even if it doesn’t inspire much confidence
Annovis Bio had my biotech bull%^&! meter running red after it made a late change…
STAT+: Cognito raises $35 million for Alzheimer’s treatment device, touts benefits compared to drugs
Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device…
STAT+: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s…
STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds
As more data emerges that obesity drugs like Wegovy can reduce complications from heart and…
Life-extending epilepsy surgery performed less often in Black children, study finds
Children with drug-resistant epilepsy who are Black or insured through Medicaid may be less likely…
In experiment, electrical stimulation of the spinal cord helps a patient with Parkinson’s to walk
An experimental treatment that delivers an electrical current to the spinal cord appeared to notably…
STAT+: For Parkinson’s disease, advances spurred by Apple Watch offer a glimmer of hope
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as…
Serotonin levels are depleted in long Covid patients, study says, pointing to a potential cause for ‘brain fog’
If you’ve been following the mystery of long Covid since it emerged in 2020, you’ll…
An effort to diversify genetic research finds new variant for Parkinson’s disease in African populations
A group of Nigerian, British, and U.S. doctors have discovered a genetic variant that increases…
America’s ERs struggle with timely care for stroke patients
In the world of stroke care, time is everything. At stroke onset, a clot or…
How a beautiful symptom of a brutal dementia informs our understanding of creativity
Carol Spence’s vision is flooded with green. As her brush swoops right and swishes left,…
STAT+: For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones
Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette…
STAT+: Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly
More than two dozen prominent health policy experts are urging the Biden administration to ensure…
Mitch McConnell’s abrupt episode has an important public health takeaway
The handling of Senate Minority Leader Mitch McConnell’s abrupt medical issue this week is raising…
Why nearly half of Americans with Parkinson’s don’t see a neurologist
It took Richard Huckabee nine years to get a Parkinson’s diagnosis. A district manager for…
STAT+: Bitter infighting leads 15 chapters to break away from leading ALS advocacy group
After a bitter dispute, the ALS Association has settled a lawsuit filed by 15 chapters…
STAT+: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel
The Food and Drug Administration has removed a neurologist with financial ties to Biogen and…
STAT+: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers
Neuralink can now study its brain implant in humans after securing a go-ahead from the…
STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’
Over glasses of Chablis at Fleming by Le Bilboquet in Manhattan, two longtime friends and…
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
NEW YORK — Michael J. Fox was sitting in his Upper East Side office surrounded by…
.jpg)
Opinion: Michael J. Fox: As a Parkinson’s patient, I felt a little left behind by biology’s century — until now
Last fall in STAT, Matt Herper questioned whether the biomedical research enterprise is really laying…
STAT+: Under protest, FDA to convene advisory panel to review controversial cell therapy for ALS
The Food and Drug Administration will convene a meeting of independent advisers to review a…
STAT+: Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA
Behind the stellar commercial launch of Amylyx Pharmaceuticals’ treatment for ALS lies an uncomfortable question:…
STAT+: Leading ALS advocacy group roiled by infighting over money and priorities
A blistering battle has broken out between the ALS Association and more than a dozen…
Scientists are finding increasing evidence for a link between air pollution and neurodegenerative diseases like Alzheimer’s
The air in Mexico City was once so toxic that people watched as dead birds…
STAT+: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug pricing
File this under “What was he thinking?” The otherwise staid Milken Institute summit on health…
STAT+: “This is not a cure”: Consensus begins to emerge on new Alzheimer’s drug
NEW YORK — A consensus may be emerging about how to prescribe the new Alzheimer’s…
Opinion: Victims of domestic abuse should get the same top-notch concussion care as athletes
Two vastly different experiences — serving as a “guest coach” on the sidelines for a…
Deep brain stimulation surgery is suspended at Birmingham trust over poor clinical results
Deep brain stimulation surgery (DBS) for movement disorders has been suspended indefinitely by University Hospitals…
Elon Musk says Neuralink’s brain-machine implant could enter human studies next year
Elon Musk’s brain-machine interface company Neuralink aims to put its first implant in a human…
STAT+: On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues
In the spring of 1981, a geneticist from Indianapolis and a neurologist from Chicago got…
Opinion: Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage
Eisai’s announcement that lecanemab, its antibody drug for Alzheimer’s disease that targets the buildup of…
Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis…